Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic

Key Points

• To assess changes in the rates and numbers of newly identified cancer diagnoses before and during the COVID-19 pandemic in the United States.
• Comparative analysis tracking newly identified cancer diagnoses across baseline and COVID-19 pandemic periods.
• Significant reductions occurred in newly identified cancer cases during the COVID-19 period compared to baseline across various tumor types, including pancreatic cancer.